How to treat and investigate a healthcare worker with continuous low-grade fever, mild thrombocytopenia (reduced platelet count), and borderline elevated C-reactive protein (CRP), with normal liver and renal function, and no leukocytosis (increased white blood cell count)?

Management of Healthcare Worker with Low-Grade Fever, Mild Thrombocytopenia, and Borderline Elevated CRP

Given the clinical presentation of persistent low-grade fever with mild thrombocytopenia and borderline elevated CRP in a healthcare worker with public toilet exposure, you should immediately obtain a manual differential white blood cell count to assess for left shift, measure D-dimer levels, and strongly consider empiric doxycycline therapy while investigating for tickborne rickettsial diseases, dengue fever, and other vector-borne infections. 1, 2

Immediate Laboratory Investigations

Priority Testing (Within 12-24 Hours)

• Obtain a complete blood count with manual differential to assess for left shift (≥6% bands or total band count ≥1500 cells/mm³), which indicates bacterial infection even without leukocytosis 1
• Measure D-dimer levels - values 3-4 times normal (>1.5-2.0 μg/mL) indicate significant thrombin generation and warrant close monitoring or admission 1
• Monitor platelet counts daily as they can drop precipitously by 43% within 1-2 hours, particularly in dengue fever during days 3-7 2, 3
• Measure prothrombin time (PT) in seconds, not INR - PT >1.5 times normal suggests coagulopathy requiring intervention 1, 2
• Check fibrinogen levels if coagulopathy is suspected - maintain >1.5 g/L 1, 2

Additional Diagnostic Studies

• Blood cultures should be obtained if bacteremia is suspected, though yield may be limited 1
• Peripheral blood smear examination to look for ehrlichial morulae in leukocytes (found in 1-20% of ehrlichiosis cases) 1
• Serologic testing for tickborne diseases (R. rickettsii, E. chaffeensis, A. phagocytophilum) - obtain acute serum but do not delay treatment pending results 1
• PCR testing for ehrlichiosis and anaplasmosis using EDTA whole blood if available from reference laboratory 1
• Dengue serology and NS1 antigen given the thrombocytopenia pattern 1, 2

Clinical Assessment Priorities

Key Historical Elements to Obtain

• Detailed exposure history: outdoor activities (hiking, camping, brushy areas), tick exposures, recent travel, animal contacts including dogs 1
• Timeline of symptom onset: when fever started relative to potential exposures, progression of symptoms 1
• Bleeding manifestations: petechiae, mucosal bleeding, or other hemorrhagic signs beyond what's visible 2
• Occupational exposures: specific healthcare settings, patient populations, needlestick injuries 1

Physical Examination Focus

• Thorough skin examination for rash (may appear on arms and legs first in RMSF), tick attachment sites (scalp, axillae, inguinal regions), petechiae 1
• Assess for warning signs of severe disease: orthostatic hypotension, tachypnea, altered mental status, signs of plasma leakage 1, 2
• Document vital signs including orthostatic measurements 1

Empiric Treatment Considerations

When to Initiate Doxycycline

Start doxycycline 100 mg orally twice daily immediately if:

• History suggests tick exposure (even without documented bite - up to 40% of RMSF patients report no tick bite) 1
• Presentation occurs during April-September in endemic areas 1
• Thrombocytopenia with normal or low-normal WBC count is present 1
• Geographic location and season are consistent with tickborne rickettsial diseases 1

The combination of fever, thrombocytopenia, and borderline elevated CRP without leukocytosis is highly suggestive of tickborne rickettsial disease, and doxycycline should not be withheld pending serologic confirmation 1.

Concurrent Antimicrobial Coverage

• Consider ceftriaxone (single IM dose) if meningococcemia cannot be excluded, as it cannot be reliably distinguished from tickborne diseases on clinical grounds alone 1
• Continue empiric therapy until alternative diagnoses are reasonably excluded 1

Interpretation of Laboratory Findings

Significance of Current Results

• Mild thrombocytopenia with adequate platelet count: Common early in RMSF and ehrlichiosis; severe thrombocytopenia develops as disease progresses 1
• Borderline elevated CRP without leukocytosis: CRP >25 mg/L suggests inflammatory process, but normal CRP (≤10 mg/L) has 95% sensitivity for severe fever with thrombocytopenia syndrome vs. bacterial rickettsioses 4, 5, 6
• Normal WBC count: Frequently observed in viral infections and RMSF; does not exclude serious bacterial infection 1

Prognostic Indicators

• Elevated WBC ≥14,000 cells/mm³ or left shift ≥6% bands: High probability of bacterial infection requiring aggressive treatment 1
• Thrombocytopenia <100 × 10⁹/L: Associated with 5-fold increased risk of severe disease and correlates with mortality 1
• Rising CRP levels: CRP >200 mg/L suggests septicemia; levels correlate with infection severity 4

Monitoring Strategy

Daily Assessments Required

• Platelet counts every 24 hours (or every 4-12 hours if declining) until stable or improving 2, 3
• PT, D-dimer, and fibrinogen if coagulopathy develops or worsens 1
• Clinical response to therapy within 24-48 hours of doxycycline initiation 1
• Repeat CRP and CBC to assess treatment response 1

Criteria for Hospital Admission

• D-dimer elevation >3-4 times normal even without other severe symptoms 1
• Platelet count <100 × 10⁹/L with bleeding manifestations 2
• Development of warning signs: high hematocrit with falling platelets, plasma leakage, shock 2
• Failure to improve within 48 hours of empiric therapy 1

Common Pitfalls to Avoid

• Do not wait for serologic confirmation before initiating doxycycline if clinical suspicion is high - serology may remain negative for 3+ days 1
• Do not dismiss tickborne diseases based on absence of reported tick bite or rash 1
• Do not use INR alone for coagulation monitoring - PT ratio in seconds is more sensitive 1, 2
• Do not assume normal CRP excludes infection - it may be normal early in viral hemorrhagic fevers 5, 6
• Avoid NSAIDs and aspirin due to increased bleeding risk with thrombocytopenia 2, 3

Convalescent Follow-up

• Repeat serology at 2-4 weeks to confirm diagnosis of tickborne diseases 1
• Monitor for delayed hemolysis if artesunate is used (days 7,14,21,28) 1
• Ensure platelet count normalization before any invasive procedures 3